Cargando…
Loss of HRD functional phenotype impedes immunotherapy and can be reversed by HDAC inhibitor in ovarian cancer
In recent years, homologous recombination deficiency (HRD) has not achieved the expected substantial promotion of immunotherapeutic efficacy in ovarian cancer. This study aims to explore the role of HRD functional phenotype as a powerful biomarker in identifying HRD patients who may benefit from imm...
Autores principales: | Yang, Dong, Huang, Fu-Xue, Wei, Wei, Li, Qia-Qia, Wu, Jun-Wan, Huang, Yun, Li, Zhi-Ling, Zhang, Hai-Liang, Li, Xuan, Yuan, Qiu-Er, Chen, Qing-shan, Feng, Gong-kan, Rong, Deng, Li, Jun-Dong, Zhu, Xiao-Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092773/ https://www.ncbi.nlm.nih.gov/pubmed/37063431 http://dx.doi.org/10.7150/ijbs.79654 |
Ejemplares similares
-
Suppressive stroma-immune prognostic signature impedes immunotherapy in ovarian cancer and can be reversed by PDGFRB inhibitors
por: Yang, Dong, et al.
Publicado: (2023) -
Putative Interaction Proteins of the Ubiquitin Ligase Hrd1 in
Magnaporthe oryzae
por: Jiang, Haolang, et al.
Publicado: (2018) -
Cryo-EM structure of the protein-conducting ERAD channel Hrd1 in complex with Hrd3
por: Schoebel, Stefan, et al.
Publicado: (2017) -
HRD1 sensitizes breast cancer cells to Tamoxifen by promoting S100A8 degradation
por: Wang, YanYang, et al.
Publicado: (2017) -
Pharmacological Modulations of Nrf2 and Therapeutic Implications in Aneurysmal Subarachnoid Hemorrhage
por: Zhang, Qia, et al.
Publicado: (2023)